Updated on 2025/03/19

写真a

 
SATO Takahiko
 
Organization
Nagoya University Hospital Hematology Assistant Professor
Title
Assistant Professor

Degree 2

  1. 博士(医学) ( 2025.3   名古屋大学 ) 

  2. 学士(医学) ( 2012.3   名古屋大学 ) 

Research Areas 2

  1. Life Science / Hematology and medical oncology

  2. Life Science / Immunology

Professional Memberships 5

  1. 日本内科学会

  2. 日本血液学会

  3. 日本造血・免疫細胞療法学会

  4. 日本癌学会

  5. American Association for Cancer Research

Awards 2

  1. 第13回日本血液学会東海地方会最優秀演題賞

    2024.6   日本血液学会東海地方会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc. 

  2. Second Prize, Blood Cell Therapy Editorial Award

    2021   The Asia-Pacific Blood and Marrow Transplantation Group  

 

Papers 16

  1. Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages. Reviewed

    Sato T, Sugiyama D, Koseki J, Kojima Y, Hattori S, Sone K, Nishinakamura H, Ishikawa T, Ishikawa Y, Kato T, Kiyoi H, Nishikawa H

      Vol. 10 ( 1 )   2025.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1172/jci.insight.178146

    PubMed

  2. Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever. Reviewed

    Wakabayashi H, Terakura S, Ishigiwa K, Ohara F, Hirano S, Yokota H, Kuwano S, Furukawa K, Shimada K, Sato T, Hanajiri R, Kiyoi H

        2025.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-025-03957-7

    PubMed

  3. Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study. Reviewed

    Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H

    eJHaem   Vol. 4 ( 2 ) page: 358 - 369   2023.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jha2.677

    PubMed

  4. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation. Reviewed

    Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S

    Frontiers in immunology   Vol. 13   page: 811733   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fimmu.2022.811733

    PubMed

  5. Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors. Reviewed

    Sato T, Goto M, Ohbiki M, Goto T, Morishita T, Seto A, Ozawa Y, Miyamura K

    International Journal of Hematology   Vol. 114 ( 6 ) page: 682 - 690   2021.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-021-03206-7

    PubMed

  6. A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma. Reviewed

    Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T

    Transplantation and cellular therapy   Vol. 27 ( 11 ) page: 928.e1 - 928.e7   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jtct.2021.07.010

    PubMed

  7. A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.

    Ando T, Sato T, Kurahashi S, Kawaguchi Y, Kagaya Y, Ozawa Y, Hirano S, Goto Y, Mano K, Yokoi S, Nakamura T, Murakami A, Noda S, Kimura S, Sone J, Kuru S, Sobue G, Katsuno M

    Nagoya journal of medical science   Vol. 83 ( 3 ) page: 641 - 647   2021.8

     More details

    Language:English  

    DOI: 10.18999/nagjms.83.3.641

    PubMed

  8. Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.

    Satoh K, Kobayashi Y, Fujimaki K, Hayashi S, Ishida S, Sugiyama D, Sato T, Lim K, Miyamoto M, Kozuma S, Kadokura M, Wakita K, Hata M, Hirahara K, Amano M, Watanabe I, Okamoto A, Tuettenberg A, Jonuleit H, Tanemura A, Maruyama S, Agatsuma T, Wada T, Nishikawa H

    International immunology   Vol. 33 ( 8 ) page: 435 - 446   2021.7

     More details

    Language:English  

    DOI: 10.1093/intimm/dxab027

    PubMed

  9. A case of reexpansion pulmonary edema and acute pulmonary thromboembolism associated with diffuse large B-cell lymphoma treated with venovenous extracorporeal membrane oxygenation.

    Kazama S, Hiraiwa H, Kimura Y, Ozaki R, Shibata N, Arao Y, Oishi H, Kato H, Kuwayama T, Yamaguchi S, Kondo T, Furusawa K, Morimoto R, Okumura T, Bando YK, Sato T, Shimada K, Kiyoi H, Nakamura G, Yasuda Y, Kasugai D, Ogawa H, Higashi M, Yamamoto T, Jingushi N, Ozaki M, Numaguchi A, Goto Y, Matsuda N, Murohara T

    Journal of cardiology cases   Vol. 23 ( 1 ) page: 53 - 56   2021.1

     More details

    Language:English  

    DOI: 10.1016/j.jccase.2020.08.013

    PubMed

  10. Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignancies.

    Sato T, Kawashima N, Ito M, Atsuta Y, Kagaya Y, Seto A, Morishita T, Fukushima N, Ozawa Y, Miyamura K

    Blood cell therapy   Vol. 3 ( 4 ) page: 84 - 91   2020.11

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.31547/bct-2020-007

    PubMed

  11. Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications.

    Morishita T, Okabe M, Kawaguchi Y, Lee Y, Ohbiki M, Osaki M, Goto M, Araie H, Sato T, Goto T, Ozawa Y, Miyamura K

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation   Vol. 24 ( 12 ) page: 2509 - 2516   2018.12

     More details

    Language:English  

    DOI: 10.1016/j.bbmt.2018.07.029

    PubMed

  12. Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.

    Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M

    Bone marrow transplantation   Vol. 53 ( 10 ) page: 1359 - 1363   2018.10

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.1038/s41409-018-0197-2

    PubMed

  13. Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.

    Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I

    Medicine   Vol. 96 ( 50 ) page: e9160   2017.12

     More details

    Language:English  

    DOI: 10.1097/MD.0000000000009160

    PubMed

  14. Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.

    Kawashima N, Inamoto Y, Sato T, Nakashima M, Kagaya Y, Watakabe K, Seto A, Fukushima N, Kurahashi S, Ozawa Y, Miyamura K

    Bone marrow transplantation   Vol. 51 ( 6 ) page: 869 - 71   2016.6

     More details

    Language:English  

    DOI: 10.1038/bmt.2016.15

    PubMed

  15. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.

    Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, Matsuyama Y, Yamaguchi T, Osada H, Suzuki M, Takahashi T

    Oncogene   Vol. 28 ( 38 ) page: 3371 - 9   2009.9

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.1038/onc.2009.201

    PubMed

  16. Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.

    Ebi H, Tomida S, Takeuchi T, Arima C, Sato T, Mitsudomi T, Yatabe Y, Osada H, Takahashi T

    Cancer research   Vol. 69 ( 9 ) page: 4027 - 35   2009.5

     More details

    Language:English  

    DOI: 10.1158/0008-5472.CAN-08-3403

    PubMed

▼display all

Presentations 8

  1. 抗PD-L1抗体治療後に免疫関連有害事象として後天性赤芽球癆を発症した一例

    佐藤貴彦, 長谷哲成, 古川勝也, 葉名尻良, 牛島洋子, 島田和之, 石川裕一, 寺倉精太郎, 清井仁

    第13回日本血液学会東海地方会  2024.6.9  日本血液学会東海地方会

     More details

    Event date: 2024.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:名古屋   Country:Japan  

  2. Sustained inhibition of CSF1R signaling effectively augments antitumor immune responses through inhibiting tumor-associated macrophages International conference

    Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Tomohiro Ishikawa, Yuichi Ishikawa, Takuma Kato, Hitoshi Kiyoi, Hiroyoshi Nishikawa

    American Association for Cancer Research (AACR) Annual Meeting 2024  2024.4.8  American Association for Cancer Research

     More details

    Event date: 2024.4

    Language:English   Presentation type:Poster presentation  

    Venue:San Diego   Country:United States  

  3. 大細胞型B細胞リンパ腫患者に対するCAR-T細胞療法の高齢者と若年者における効果と安全性の比較

    葉名尻 良, 佐藤 貴彦, 古川 勝也, 牛島 洋子, 島田 和之, 石川 裕一, 寺倉 精太郎, 清井 仁

    第47回日本造血・免疫細胞療法学会総会  2025.2.28  日本造血・免疫細胞療法学会

     More details

    Event date: 2025.2 - 2025.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:大阪   Country:Japan  

  4. Axi-cel投与後早期の発熱による重症CAR-AEの予測

    若林浩也, 寺倉精太郎, 石際康平, 小原史也, 平野志帆, 横田裕史, 桑野史穂美, 古川勝也, 島田和之, 佐藤貴彦, 葉名尻良, 清井仁

    第47回日本造血・免疫細胞療法学会総会  2025.3.1  日本造血・免疫細胞療法学会

     More details

    Event date: 2025.2 - 2025.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:大阪   Country:Japan  

  5. 末梢血CAR T細胞におけるCD4/CD8比がB細胞リンパ腫の治療効果と毒性に与える影響

    葉名尻良, 佐藤 貴彦, 古川 勝也, 牛島 洋子, 島田 和之, 石川 裕一, 寺倉 精太郎, 清井 仁

    第86回日本血液学会学術集会  2024.10.11  日本血液学会

     More details

    Event date: 2024.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:京都   Country:Japan  

  6. AML-PDX治療モデルのシングルセル解析によるFLT3阻害剤耐性化機構の解明

    金 貞姫, 石川 裕一, 牛島 洋子, 佐藤 貴彦, 鈴木 祐太朗, 西野 貴紀, 鵜飼 俊, 岩田 哲, 紅 朋浩, 日野原 邦彦, 清井 仁

    第86回日本血液学会学術集会  2024.10.11  日本血液学会

     More details

    Event date: 2024.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:京都   Country:Japan  

  7. Novel CSF1R inhibitor, FF-10101, strongly inhibit tumor-associated macrophages and improve anti-tumor response

    Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Yuichi Ishikawa, Hiroyoshi Nishikawa, Hitoshi Kiyoi

    2023.9.21 

     More details

    Event date: 2023.9

    Language:English   Presentation type:Oral presentation (general)  

    Country:Japan  

  8. FF-10101, a novel CSF1R inhibitor, strongly inhibit tumor-associated macrophages and improve anti-tumor response International conference

    Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Yuichi Ishikawa, Hitoshi Kiyoi, Hiroyoshi Nishikawa

    2nd JCA-AACR Precision Cancer Medicine International Conference  2023.6.29 

     More details

    Event date: 2023.6

    Language:English   Presentation type:Poster presentation  

    Venue:Kyoto   Country:Japan  

▼display all